Cryoport, Inc. (CYRX)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Jerrell W. Shelton | Chairman, President & CEO | 865.6k | 5.94M | 1945 |
Mr. Robert S. Stefanovich MS | CFO & Treasurer | 547.64k | 553.53k | 1965 |
Mr. Edward J. Zecchini | Senior VP and Chief Digital & Technology Officer | 85k | -- | 1962 |
Dr. Mark W. Sawicki Ph.D. | Chief Scientific Officer | 547.64k | 130 | -- |
Mr. Thomas J. Heinzen | Vice President of Corporate Development & Investor Relations | -- | -- | -- |
Mr. Tony Ippolito | VP, General Counsel & Corporate Secretary | -- | -- | -- |
Ms. Kylie A. Crowe | Vice President of Global Human Resources & Organizational Development | -- | -- | -- |
Mr. Bret Bollinger | VP & Chief Innovation Officer | 140.49k | -- | 1967 |
Mr. Phil Wilson | Chief Operating Officer of Cryoport Systems, LLC | -- | -- | -- |
Cryoport, Inc.
- Sector:
- Industrials
- Industry: Integrated Freight & Logistics
- Full Time Employees:
- 1,019
Description
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.
Corporate Governance
Recent Events
- Apr 03, 2024DEF 14A: Proxy StatementsSee Full Filing
- Mar 13, 202410-K: Periodic Financial ReportsSee Full Filing
- Mar 12, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Feb 15, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Feb 08, 2024SC 13G: Tender Offer/Acquisition ReportsSee Full Filing